The CMO/Biostatistician Connection – Driving Clinical Development Efficiency
Автор: Cytel
Загружено: 2016-05-16
Просмотров: 278
Recorded at the CMO Summit East, Boston, May 2016
Dr. Lou Vaickus (aktaPD) and Jim Bolognese (Cytel) cite case studies illustrating how a sound statistical strategy plan in early stage biopharma development saves time and money. They challenge the New England CMO audience to shift psyches from the utilitarian use of biostatistics and vintage methodologies. This pioneering, yet proven strategy is vital to realizing a modern and effective clinical development plan.
Dialog highlights:
Signal markers and how to improve them
Pointers for investors’ optimization of (and insurance for) funding proof-of-concept/Phase 1 trials
What’s hot – and what’s not – in biostatistics: focus on "probability of success" not simply "p values"
Learn more at cytel.com, and aktapd.com
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
